In a report released today, Jason McCarthy from Maxim Group maintained a Buy rating on Moleculin Biotech (MBRX), with a price target of $3. The company’s shares opened today at $1.27. McCarthy commented: “Following last month’s clearance to begin its European clinical trial of WP1220 (STAT3 inhibitor) in the topical treatment of cutaneous T-cell lymphoma […]

Historical memory and how it is understood play a major role in forming civic solidarity, creating links between generations and making citizens feel like they have a personal stake in the state affairs.

I seldom comment on Brexit, largely because I neither see leaving the EU as a panacea nor the EU itself as a Utopia, and am alienated by the over-extravagant passions and claims on both sides. In addition to that, the FCO is largely excluded from Brexit negotiations, being perceived by the Tories as a nest […]